Physician profile
Scott W Nutter
NPI 1972782142
$840.07
in general payments reported to CMS, 2019-2025
15 companies · $18.84 in 2025
The $18.84 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $80.02 · 2021: $103 · 2022: $85.75 · 2023: $37.29 · 2024: $82.67 · 2025: $18.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $141.60 | 2019-2020 | |
| Horizon Therapeutics Plc | $131.89 | 2019-2020 | |
| Sebela Pharmaceuticals INC. | $102.91 | 2019-2023 | Naftin |
| Paratek Pharmaceuticals, INC. | $74.20 | 2021-2024 | Nuzyra |
| Heron Therapeutics, INC. | $70.54 | 2021-2022 | |
| Smith+Nephew, INC. | $65.79 | 2019-2020 | |
| Organogenesis INC. | $63.22 | 2019 | |
| Kerecis Limited | $50.09 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Bioventus LLC | $31.83 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Nevro Corp. | $24.37 | 2022 | |
| Glenmark Therapeutics INC. | $20.00 | 2019 | |
| Linvatec Corporation | $18.84 | 2025 | In2bones USA, Neospan, Hercules Suture Anchor System |
| Zimmer Biomet Holdings, INC. | $17.38 | 2019 | |
| Arthrosurface Incorporated | $14.47 | 2019 | |
| Journey Medical Corporation | $12.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Nutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.